Insider · CIK 0001207833

ORONSKY ARNOLD L

Reports to the SEC for 22 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001207833

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-10-01	KalVista Pharmaceuticals, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.62M sh	—	—	1,675,656
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+3.49M sh	—	—	5,164,054
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.04M sh	—	—	6,204,708
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+265K sh	—	—	6,469,911
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series Seed Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.62M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.49M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.04M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−265K sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.62M sh	—	—	1,675,101
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+3.49M sh	—	—	5,163,499
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.04M sh	—	—	6,204,153
2020-09-29	PMVPPMV Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+265K sh	—	—	6,469,356
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series Seed Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.62M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.49M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.04M sh	—	—	0
2020-09-29	PMVPPMV Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−265K sh	—	—	0
2020-09-25	PMVPPMV Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+55.6K sh	$18.00	+$1M	55,555
2020-09-25	PMVPPMV Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+55K sh	$18.00	+$990K	55,000
2020-05-28	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-10-02	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-05-30	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-10-03	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2018-09-10	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+58.8K sh	$17.00	+$1M	388,766
2018-08-07	TESARO, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	12,479
2018-08-07	TESARO, Inc.S Sale	Director	SSale	−10K sh	$26.77	−$268K	2,479
2018-08-07	TESARO, Inc.Director Nonqualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2018-05-31	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-09-27	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-06-02	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2017-06-01	TESARO, Inc.A Award	Director	AAward	+335 sh	—	—	1,338
2017-06-01	TESARO, Inc.Director Nonqualified Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPX Exercise of In-Money	Director	XExercise of In-Money	+3,559 sh	—	—	1,404,515
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPX Exercise of In-Money	Director	XExercise of In-Money	+101 sh	—	—	40,181
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPX Exercise of In-Money	Director	XExercise of In-Money	+28 sh	—	—	11,208
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPWarrant to buy CommonX Exercise of In-Money	Director	XExercise of In-Money	−11.5K sh	—	—	0
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPWarrant to buy CommonX Exercise of In-Money	Director	XExercise of In-Money	−328 sh	—	—	0
2017-04-24	APPLIED GENETIC TECHNOLOGIES CORPWarrant to buy CommonX Exercise of In-Money	Director	XExercise of In-Money	−91 sh	—	—	0
2017-03-23	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-02-28	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2016-06-01	TESARO, Inc.Director Nonqualified Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2016-05-31	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2016-03-18	TESARO, Inc.P Purchase	Director	PPurchase	+142K sh	$35.19	+$5M	2,013,786
2015-11-19	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+6,200 sh	—	—	6,200
2015-10-13	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2015-06-01	TESARO, Inc.A Award	Director	AAward	+1,003 sh	—	—	10,096
2015-06-01	TESARO, Inc.Director Nonqualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-05-27	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-01-12	TESARO, Inc.J Other	Director	JOther	−600K sh	—	—	1,871,701
2015-01-12	TESARO, Inc.J Other	Director	JOther	+6,000 sh	—	—	6,000

Recent filings

Accepted (ET)
Oct 24
ORONSKY ARNOLD L0001209191-20-053394
SEC(opens sec.gov)
Oct 24/A
ORONSKY ARNOLD L0001209191-20-053346
SEC(opens sec.gov)
Sep 294
ORONSKY ARNOLD L0001209191-20-052334
SEC(opens sec.gov)
May 294
ORONSKY ARNOLD L0001209191-20-032958
SEC(opens sec.gov)

Insider transactions

Recent filings

Companies

Address